Expression of P-gp is the main barrier in chemotherapy for hematological malignancies, including acute myeloid leukemia (Mahadevan and List, 2004; Chekhun et al., 2006; de Moraes et al., 2013; Gao et al., 2015). The gene discussed is PGP; the disease is acute myeloid leukemia.